North American company
Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Exscientia PLC is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs. Its patient-first AI process is comprised of Precision Target, Precision Design, Precision Experiment, and Precision Medicine. Its revenue is generated from Service fees related to drug discovery collaboration agreements it is utilizing its proprietary technology to develop novel Intellectual Property (IP); and Licensing fees related to drug discovery agreements.
Latest EXAI News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News